HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2,2- (7- (2- (3- hydroxy- 2- oxopyridin- 1(2H)- yl)ethyl)- 1,4,7- triazonane- 1,4- diyl)diacetic acid

structure in first source

Also Known As:

HE-NO2A

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - 2,2-(7-(2-(3-hydroxy-2-oxopyridin-1(2H)-yl)ethyl)-1,4,7-triazonane-1,4-diyl)diacetic acid: 1
Organic Chemicals: 133
- Triazenes: 36
  - 2,2-(7-(2-(3-hydroxy-2-oxopyridin-1(2H)-yl)ethyl)-1,4,7-triazonane-1,4-diyl)diacetic acid: 1

Experts

1.	Gai, Yongkang: 1 article (01/2018)
2.	Ke, Lei: 1 article (01/2018)
3.	Ma, Xiang: 1 article (01/2018)
4.	Wang, Sheng: 1 article (01/2018)
5.	Xiang, Guangya: 1 article (01/2018)
6.	Zhang, Shasha: 1 article (01/2018)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2018 - "In the current study, a series of 1,4,7-triazacyclononane derivatives HE-NO2A, HP-NO2A and NE2P2A, as well as the bifunctional chelators p-NO2-PhPr-NE3TA and p-NH2-PhPr-NE3TA were synthesized and evaluated as iron-depleting agents for the potential anti-cancer therapy against human hepatocellular carcinoma. "
2.	Hepatocellular Carcinoma (Hepatoma) 01/01/2018 - "In the current study, a series of 1,4,7-triazacyclononane derivatives HE-NO2A, HP-NO2A and NE2P2A, as well as the bifunctional chelators p-NO2-PhPr-NE3TA and p-NH2-PhPr-NE3TA were synthesized and evaluated as iron-depleting agents for the potential anti-cancer therapy against human hepatocellular carcinoma. "

Related Drugs and Biologics

1.	Iron
2.	Chelating Agents
3.	1,4,7-triazacyclononane
4.	2,2- (7- (3- (3- hydroxy- 2- oxopyridin- 1(2H)- yl)propyl)- 1,4,7- triazonane- 1,4- diyl)diacetic acid

Related Therapies and Procedures

1.	Therapeutics